Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ascent Industries (ACNT) Shares Outstanding (Diluted Average) (2016 - 2025)

Ascent Industries (ACNT) has disclosed Shares Outstanding (Diluted Average) for 16 consecutive years, with $9.6 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Shares Outstanding (Diluted Average) fell 4.58% year-over-year to $9.6 million, compared with a TTM value of $9.6 million through Dec 2025, down 4.58%, and an annual FY2025 reading of $9.6 million, down 4.58% over the prior year.
  • Shares Outstanding (Diluted Average) was $9.6 million for Q4 2025 at Ascent Industries, up from $9.4 million in the prior quarter.
  • Across five years, Shares Outstanding (Diluted Average) topped out at $10.5 million in Q3 2022 and bottomed at $9.3 million in Q1 2021.
  • Average Shares Outstanding (Diluted Average) over 5 years is $9.9 million, with a median of $10.1 million recorded in 2024.
  • The sharpest move saw Shares Outstanding (Diluted Average) rose 11.98% in 2022, then decreased 7.27% in 2025.
  • Year by year, Shares Outstanding (Diluted Average) stood at $9.5 million in 2021, then grew by 10.09% to $10.4 million in 2022, then fell by 2.59% to $10.1 million in 2023, then dropped by 0.34% to $10.1 million in 2024, then decreased by 4.58% to $9.6 million in 2025.
  • Business Quant data shows Shares Outstanding (Diluted Average) for ACNT at $9.6 million in Q4 2025, $9.4 million in Q3 2025, and $9.8 million in Q2 2025.